SDIC Venture Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Biocytogenbiocytogen.com.cn in 𝕏Apr 2018 · $65M

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs.

BiotechDeep TechHealthtechBeijing, CN

Yuelei Shen(Founder)in

Co-investorsCowin Capital Group 3E Bioventures Capital Oriza Holdings

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.